$18.00
0.18[1.01%]
At close: Apr 25
$18.00
0[0.00%]
After Hours: 6:36PM EDT
Avadel Pharmaceuticals
(NASDAQ:AVDL)Avadel Pharmaceuticals Stock (NASDAQ:AVDL), Analyst Ratings, Price Targets, Predictions
Avadel Pharmaceuticals PLC has a consensus price target of $20.7, established from looking at the 44 latest analyst ratings. The last 3 analyst ratings were released from Needham, Craig-Hallum, and Piper Sandler on April 9, 2024, March 5, 2024, and March 5, 2024. With an average price target of $22.33 between Needham, Craig-Hallum, and Piper Sandler, there's an implied 24.07% upside for Avadel Pharmaceuticals PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Craig-Hallum
Piper Sandler
Oppenheimer
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Avadel Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/09/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 22.22% | Needham | Ami Fadia | → $22 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 22.22% | Craig-Hallum | Chase Knickerbocker | $20 → $22 | Maintains | Buy | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 27.78% | Piper Sandler | David Amsellem | $18 → $23 | Maintains | Overweight | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 61.11% | Oppenheimer | Francois Brisebois | $27 → $29 | Maintains | Outperform | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 38.89% | HC Wainwright & Co. | Oren Livnat | $21 → $25 | Maintains | Buy | Get Alert |
| 03/05/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 22.22% | Needham | Ami Fadia | $20 → $22 | Maintains | Buy | Get Alert |
| 02/06/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 16.67% | UBS | Ashwani Verma | → $21 | Initiates | → Buy | Get Alert |
| 12/20/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 11.11% | Needham | Ami Fadia | $19 → $20 | Maintains | Buy | Get Alert |
| 11/09/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 5.56% | Needham | Ami Fadia | $18 → $19 | Maintains | Buy | Get Alert |
| 10/04/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Needham | Ami Fadia | → $18 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Needham | Ami Fadia | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Piper Sandler | David Amsellem | $13 → $18 | Maintains | Overweight | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Needham | Ami Fadia | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 16.67% | HC Wainwright & Co. | Oren Livnat | → $21 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Needham | Ami Fadia | → $18 | Reiterates | → Buy | Get Alert |
| 07/05/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 16.67% | HC Wainwright & Co. | Oren Livnat | $17.5 → $21 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 38.89% | Oppenheimer | Francois Brisebois | $22 → $25 | Maintains | Market Outperform | Get Alert |
| 06/30/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | — | Needham | Ami Fadia | → $18 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $18.00 | 22.22% | Oppenheimer | Francois Brisebois | → $22 | Reiterates | Outperform → Outperform | Get Alert |
FAQ
What is the target price for Avadel Pharmaceuticals (AVDL)?
The latest price target for Avadel Pharmaceuticals (NASDAQ: AVDL) was reported by Needham on April 9, 2024. The analyst firm set a price target for $22.00 expecting AVDL to rise to within 12 months (a possible 22.22% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Avadel Pharmaceuticals (AVDL)?
The latest analyst rating for Avadel Pharmaceuticals (NASDAQ: AVDL) was provided by Needham, and Avadel Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Avadel Pharmaceuticals (AVDL)?
The last upgrade for Avadel Pharmaceuticals PLC happened on November 30, 2022 when Jefferies raised their price target to $11. Jefferies previously had a hold for Avadel Pharmaceuticals PLC.
When was the last downgrade for Avadel Pharmaceuticals (AVDL)?
The last downgrade for Avadel Pharmaceuticals PLC happened on August 10, 2022 when Jefferies changed their price target from $6 to $8 for Avadel Pharmaceuticals PLC.
When is the next analyst rating going to be posted or updated for Avadel Pharmaceuticals (AVDL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avadel Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avadel Pharmaceuticals was filed on April 9, 2024 so you should expect the next rating to be made available sometime around April 9, 2025.
Is the Analyst Rating Avadel Pharmaceuticals (AVDL) correct?
While ratings are subjective and will change, the latest Avadel Pharmaceuticals (AVDL) rating was a reiterated with a price target of $0.00 to $22.00. The current price Avadel Pharmaceuticals (AVDL) is trading at is $18.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.